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Background: Both age and smoking promote endothelial dysfunction and impair vascular reactivity. Here, we
tested this hypothesis by quantifying new cardiovascular magnetic resonance (CMR)-based biomarkers in smokers
and nonsmokers.
Methods: Study population: young non-smokers (YNS: N = 45, mean age = 30.2 ± 0.7 years), young smokers
(YS: N = 39 mean age 32.1 ± 0.7 years), older non-smokers (ONS: N = 45, mean age = 57.8 ± 0.6 years), and older
smokers (OS: N = 40, mean age = 56.3 ± 0.6 years), all without overt cardiovascular disease. Vascular reactivity was
evaluated following cuff-induced hyperemia via time-resolved blood flow velocity and oxygenation (SvO2) in the
femoral artery and vein, respectively. SvO2 dynamics yielded washout time (time to minimum SvO2), resaturation
rate (upslope) and maximum change from baseline (overshoot). Arterial parameters included pulse ratio (PR),
hyperemic index (HI) and duration of hyperemia (TFF). Pulse-wave velocity (PWV) was assessed in aortic arch,
thoracoabdominal aorta and iliofemoral arteries. Ultrasound-based carotid intimal-medial thickness (IMT) and
brachial flow-mediated dilation were measured for comparison.
Results: Age and smoking status were independent for all parameters. Smokers had reduced upslope (−28.4%,
P < 0.001), increased washout time (+15.3%, P < 0.01), and reduced HI (−19.5%, P < 0.01). Among non-smokers,
older subjects had lower upslope (−22.7%, P < 0.01) and overshoot (−29.4%, P < 0.01), elevated baseline pulse ratio
(+14.9%, P < 0.01), central and peripheral PWV (all P < 0.05). Relative to YNS, YS had lower upslope (−23.6%, P < 0.01)
and longer washout time (13.5%, P < 0.05). Relative to ONS, OS had lower upslope (−33.0%, P < 0.01). IMT was
greater in ONS than in YNS (+45.6%, P < 0.001), and also in YS compared to YNS (+14.7%, P < 0.05).
Conclusions: Results suggest CMR biomarkers of endothelial function to be sensitive to age and smoking
independent of each other.
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Cigarette smoking is a major modifiable risk factor for
systemic atherosclerosis and thus cardiovascular disease
(CVD) [1]. It is estimated that cigarette smoking is re-
sponsible for over 10% of CVD related deaths [2]. Ac-
cording to World Health Organization statistics,
smoking was “the primary causal factor for at least 30%
of all cancer deaths, for nearly 80% of deaths from
chronic obstructive pulmonary disease, and for early car-
diovascular disease and deaths during the period from
2000 to 2004” [3]. Based on Framingham heart study,
the hazard ratio of smoking ranked second, next to dia-
betes, among all CVD risk factors [4].
Endothelial dysfunction (EDF), characterized by a re-
duction in the bioavailability of nitric oxide (NO), is the
earliest stage of atherogenesis [5], resulting in increased
inflammation, inadequate vasodilation, and thrombosis
[6,7]. Various conditions, including hypertension, hyper-
cholesterolemia, diabetes mellitus, etc., but also advanced
age, result in reduced release of NO either because of im-
paired synthesis or bioavailability [8]. Cigarette smoking
has long been known to produce reactive oxygen species
(ROS) [9], which damage the endothelium, thereby caus-
ing a reduction in NO bioavailability and, in turn, im-
paired endothelium-dependent vasodilation [10].
Several non-invasive imaging methods exist for asses-
sing the vascular manifestations of endothelial dysfunc-
tion. Flow-mediated dilation (FMD) measured by B-mode
ultrasound in the brachial artery in response to cuff-
induced ischemia is considered a surrogate measure of
EDF [11], used in the research setting since the 1990s.
Celermajer et al. found reduced FMD to be independently
associated with cigarette smoking as was older age
(P < 0.01) [12]. However, FMD is difficult to measure given
the small changes in vessel diameter caused during
hyperemia (typically 3-8%) [13] and intra-subject reprodu-
cibility is still a major challenge [14]. Further, changes in
intima-media thickness (IMT) of the carotid artery mea-
sured via B-mode ultrasound, have provided important
insight into early manifestations of atherogenesis [15].
IMT data show strong associations with cigarette smoking
indicating increased values in active smokers, and to a
lesser extent in past smokers and even in passive smoking
[16]. However, there is also evidence that the method has
limitations in terms of reproducibility, resulting from high
inter- and intra- observer variability [15].
Another image-based metric of vascular health is
pulse-wave velocity (PWV), a parameter that measures
arterial stiffness [17,18], i.e. the propagation speed of the
systolic pulse-wave measured from the delayed arrival of
the pulse pressure wave at some downstream location.
There are a number of studies comparing PWV or its
surrogates between smokers and nonsmokers, with often
conflicting results (see, Doonan et al. for a literaturereview [19]). The major limitation of conventional to-
nometry is that the path length of the pressure wave
cannot be determined accurately. A small cardiovascular
magnetic resonance (CMR) study compared distensibil-
ity, expressed as the change in cross-sectional area di-
vided by pulse pressure in the aorta and common
carotid artery, showing a significant reduction in young
smokers relative to their non-smoking peers [20].
In this study, we applied new CMR methods developed
in the authors’ laboratory that provide surrogate mea-
sures of vascular reactivity and endothelial dysfunction
to evaluate effects of age and smoking on vascular health
in subjects without symptomatic cardiac disease. We hy-
pothesized that parameters characterizing micro- and
macro-vascular reactivity are impaired in smokers rela-
tive to age-matched non-smokers in a manner similar to
the effects that advanced age is expected to have on the
vascular system. Methods incorporated into a single
examination protocol include dynamic venous oximetry
that makes use of venous oxygen saturation as an en-
dogenous tracer [21] monitored during hyperemia, along
with arterial velocity [22]. PWV is measured in the cen-
tral and peripheral arteries using new projection imaging
techniques [23,24]. Lastly, the CMR measures are com-
pared with conventional ultrasound measures that in-
clude carotid IMT and brachial FMD.
Methods
Subjects
A total of 169 subjects divided into four groups were stud-
ied: young healthy non-smokers (YNS: N = 45, mean
age = 30.2 ± 0.7 years, age range: 26–40 years), age-
matched young smokers (YS: N = 39, mean age = 32.1 ±
0.7), older healthy non-smokers (ONS: N = 45, mean
age = 57.8 ± 0.6 years, age range: 51–65 years), and age-
matched older smokers (OS: N = 40, age = 56.3 ± 0.6). Full
details of the study population are given in Table 1. All
subjects had their resting heart rate, systolic and diastolic
blood pressure measured upon enrollment and a lipid
profile was obtained, and C-reactive protein assayed. All
study participants were free of symptomatic cardiovascu-
lar disease. Subjects were requested to refrain from eating,
exercise, taking vasoactive medications (including over-
the-counter medications such as vitamin C), and smokers
from smoking for 12 hours prior to the imaging proce-
dures. Written informed consent was obtained prior to all
examinations following an institutional review board-
approved protocol. Total smoking exposure in terms of
cigarette pack-years was 7.34 ± 0.76 and 12.57 ± 2.20 for
young and older smokers, respectively.
Magnetic resonance imaging
All MR procedures were performed on a 3 T Siemens
TIM Trio imager (Siemens Medical Solutions) using an
Table 1 Subject and cardiovascular characteristics (means ± standard error)
Groups Y-NS (N = 45) Y-S (N = 39) O-NS (N = 45) O-S (N = 40)
Age (years) 30.2 ± 0.7 32.1 ± 0.7 57.8 ± 0.6 56.3 ± 0.6
Men 17 20 13 22
White 29 16 29 14
Black 6 21 9 26
Asian 10 2 7 0
SBP (mmHg) 115.4 ± 1.9** 116.7 ± 2.2 122.7 ± 2.7** 127.3 ± 2.2
DBP (mmHg) 73.4 ± 1.2 75.3 ± 1.9 76.7 ± 1.5 81.0 ± 1.5
MAP (mmHg) 87.5 ± 1.2 89.1 ± 1.9 91.6 ± 1.8 96.4 ± 1.6
HR (bpm) 75.6 ± 1.8 75.2 ± 2.3 75.9 ± 1.3 76.9 ± 1.7
BMI (kg/m2) 23.4 ± 0.5* ** 26.1 ± 0.7* 26.2 ± 0.6** 26.5 ± 0.6
Total Chol (mg/dL) 170.5 ± 4.8** 172.7 ± 6.4 196.2 ± 5.7** 196.3 ± 6.2
LDL (mg/dL) 98.5 ± 3.7** 103.6 ± 5.6 123.0 ± 5.1** 121.4 ± 5.4
HDL (mg/dL) 57.5 ± 2.1* 48.7 ± 2.4* 55.5 ± 2.5 54.6 ± 2.4
Triglycerides (mg/dL) 70.9 ± 4.9 95.5 ± 11.1 95.3 ± 12.2 117.2 ± 14.5
CRP (mg/L) 1.3 ± 0.2 2.0 ± 0.4 1.8 ± 0.3^ 4.6 ± 1.0^
MAP (mean arterial pressure), calculated as MAP = SBP/3 + DBPx2/3 (SBP = systolic blood pressure, DBP = diastolic blood pressure), HR = heart rate, BMI = body
mass index, Chol = cholesterol, LDL = low-density lipoprotein cholesterol, HDL = high-density lipoprotein cholesterol, CRP = C-reactive protein.
*P < 0.05, young smokers versus young non-smokers.
^P < 0.05, older smokers versus older non-smokers.
**P < 0.05, young non-smokers versus older non-smokers.
Langham et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:19 Page 3 of 148-channel extremity coil for studies at the location of
the femoral/popliteal artery and vein (Part I), and a com-
bination of two body matrix and spine coils for PWV of
the aorta, iliac and femoral circulation (Part II). All
custom-designed pulse sequences were implemented in
SequenceTree [25]. Each part of the CMR protocol, in-
cluding scout scans, lasted approximately 20 mins and
the patients were scanned in feet-first supine position.
CMR assessment of peripheral vascular reactivity
Measures of vascular reactivity were obtained as the post-
occlusion change relative to baseline values. Time-resolved
blood flow velocity and oxygen saturation (SvO2) were
measured simultaneously in the femoral artery and vein,
respectively (thereby requiring a single cuff occlusion only)
with a multi-echo gradient-recalled echo (GRE) sequence
described previously [24]. Briefly, lower limb ischemia was
induced by applying a blood pressure cuff (SC120D model,
Hokanson, Bellevue, WA, USA) to the upper right thigh,
i.e. on the adductor longus region. The cuff was inflated to
75 mmHg above the subject’s systolic blood pressure
(SBP), but not exceeding 250 mmHg. The cuff paradigm
consisted of 2 minutes of baseline, 5 minutes of cuff occlu-
sion, and 6 minutes of recovery. During the baseline (pre-
occlusion) period, blood flow velocity and oxygenation
were quantified successively. Ten seconds prior to cuff re-
lease the pulse sequence was launched to time-resolve ar-
terial blood flow velocity and venous oxygenation
simultaneously with temporal resolution of 120 ms and
1.25 s, respectively, for a period of 70 seconds.Ungated absolute blood flow velocity was obtained by
means of a projection technique [21]. During baseline,
the velocity-encoding parameter, referred to as VENC
(determining the highest velocity that can be unambigu-
ously measured), was set to 80 cm/s and temporal reso-
lution was 20 ms. During the post-occlusion (hyperemia)
period, during which arterial velocity is significantly
greater, VENC = 125 cm/s and 175 cm/s were selected,
at a temporal resolution of 120 ms (reduction in the
temporal resolution results from interleaving velocimetry
and oximetry, see below). Sample arterial flow data at
baseline and during hyperemia are shown in Figure 1.
The fractional blood oxygenation level (%HbO2) in the
femoral vein was estimated by field mapping [26], yielding
the magnetic susceptibility difference between intravascu-
lar blood and surrounding tissue [27]. A representative
plot of SvO2 versus time, along with phase difference im-
ages during hyperemia is shown in Figure 2.
Measurement of Pulse-Wave Velocity (PWV)
Central and peripheral regional pulse-wave velocities
were quantified in the same imaging session following
the cuff protocol as described previously [28]. The
protocol starts with acquisition of a series of oblique sa-
gittal slices for visualizing the ascending and descending
aorta. Multiple axial slices are then acquired below the pul-
monary trunk to image both ascending and proximal de-
scending aorta in the same imaging plane. Subsequently, a
suitable slice and readout direction are selected for the
ungated acquisition of velocity-encoded projections at a
Figure 1 CMR-based femoral artery blood-flow velocity measurement: a) gray-scale magnitude image showing femoral artery and vein;
b) time-resolved velocity (temporal resolution, 20 ms) in the femoral artery at baseline and, c) during hyperemia (temporal resolution,
120 ms). Projection images in (b) display velocity as a function of time for three heart beats, and plots below represent averages across arterial
lumen showing normal tri-phasic waveform, with peak systolic velocity, Vs, peak retrograde velocity, Vr, and peak antegrade velocity, Va, indicated.
Dashed line defines the zero velocity. During hypermia after cuff release (c) velocity is elevated indicating forward flow only, returning to baseline after
approximately 15 s. Horizontal black arrow in (c) marks the forward flow duration (i.e. period of hyperemia, TFF).
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10–12 cardiac cycles. VENC of 180 cm/s was chosen,
thereby ensuring accurate mapping of the velocity-time
curve with complex difference intensity at the “foot” of the
systolic upstroke, which is needed to determine the pulse
pressure transit time via “foot-to-foot” method [18].
Thoracoabdominal aorta and iliofemoral PWV were
obtained analogously except that the velocity-encoded
projections were collected simultaneously at two slice lo-
cations. For thoracoabdominal aortic PWV measure-
ment velocity-encoded projections were collected at aFigure 2 Quantification of reactive hyperemia with dynamic oximetry. a
inferior boundary of the pressure cuff; b) post-ischemia (cuff-release at t = 0) f
images showing relative phase of venous blood during period indicated by h
levels. Parametrization of the curve in panel c yields washout time, time of m
curve following minimum), and overshoot, denoting the maximum of the SvOproximal location of the descending aorta as well as dis-
tally in the abdominal aorta (superior to the iliac bifur-
cation). Finally, for the peripheral iliofemoral PWV the
coils were positioned over the abdomen and upper
thighs to enable simultaneous acquisition of projections
at a slice inferior to the iliac bifurcation and a slice su-
perior to the popliteal artery. The slightly lower tem-
poral resolution of 12 ms is compensated by the greater
path length of the pulse pressure wave therefore yielding
similar precision at this site. VENC values used were
125 cm/s for thoracoabdominal aorta and 75 cm/s for) Cross-sectional phase difference image of the thigh, 10 cm below the
emoral vein oxygen saturation (SvO2) curve; c) zoomed series of phase
orizontal black bar. Darker blue represent represents lower saturation
inimum following cuff release, upslope (slope of the linear portion of the
2 curve relative to baseline (preceding cuff contraction, not shown).
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plex difference signal intensity. The method is illustrated
with sample data in Figure 3.
The integrated CMR protocol and metrics quantified
are summarized in Figure 4. The figure graphically illus-
trates the locations of the measurements described
above. All analyses were performed by investigators
blinded to patient information.CMR data analysis
Quantification of time-resolved blood flow velocity in the
femoral artery
Baseline (i.e. pre-occlusion) velocities derived from the im-
ages (Figure 1a, b) were averaged over multiple heart beats
(typically 6–8 beats), yielding peak-systolic velocity (Vs),
peak-retrograde velocity (Vr), and peak late antegrade vel-
ocity (Va). From these parameters the pulse ratio (PR) [29],
defined as the ratio of systolic and diastolic pulsatility, (Vs-
Vr)/(Va-Vr), was computed (Figure 1b) instead of the pulsa-
tility index to avoid quantifying average baseline velocity
over a cardiac cycle as the latter is predominantly weighted
by diastole (low velocity-to-noise ratio) due to the mis-
match between VENC (80 cm/s) and blood flow velocity
(<5 cm/s). Parameters related to hyperemia included time
of forward flow (TFF) (Figure 1c), and hyperemic index
(HI) defined as the ratio of hyperemic peak flow velocity
(Vmax) to (Va-Vr).Figure 3 Measurement of pulse-wave velocity: Reference axial image
difference intensity (|CD|) images (b, d). Velocity-encoded projections w
systolic peaks are clearly visible on the corresponding velocity images (b a
(e) show three cardiac cycles. Note temporal offset in the arrival of the pul
iliac artery. Venous flow velocity is lower by an order of magnitude compa
arterial |CD|.Quantification of time-resolved SvO2 in the femoral vein
First, magnetic field inhomogeneity was corrected to
reduce the effects of large-scale static field inhomogen-
eity [30]. Subsequently, SvO2 was computed from the
phase difference between the femoral vein and artery, in-
corporating individual hematocrit level determined from
blood sample. The femoral artery, located adjacent to
the femoral vein (Figure 2a), was chosen to minimize
observer-dependent selection of a reference region [24].
The SvO2 time-course curve was parameterized yielding
washout time, upslope and overshoot [22] (Figure 2b).
The washout time is the time elapsed to observe the
oxygen-depleted capillary blood at the imaging slice after
cuff deflation at t = 0 s. Upslope and overshoot are de-
fined as the mean resaturation rate during hyperemia
and the subsequent maximal above-baseline SvO2 level,
respectively. Baseline SvO2 is the average of four pre-
cuff (2 mins baseline period) quantifications.
Pulse-wave velocity quantification
The complex difference intensity [31] signals from prox-
imal and distal slices were spatially averaged along the
readout direction within the vessel boundary for each
time point (temporal resolution = 7.4 ms for aortic arch
PWV and 12 ms for thoracoabdominal and iliofemoral
PWVs). The time courses from proximal and distal loca-
tions were then plotted jointly to determine the propaga-
tion time of the wave-front (Figure 3a) [28]. Estimations (superior, a, and inferior, c) and temporally-resolved complex
ere acquired simultaneously for quantifying iliofemoral PWV. The
nd d). The time-courses of right iliac and femoral artery |CD| images
se pressure wave in the distal femoral artery with respect to proximal
red to arterial flow velocity thus they are not visible or interfere with
Figure 4 Schematic of imaging protocol and parameters measured, comprising measurement of vascular reactivity via arterial velocimetry
and venous oximetry at rest and hyperemia and measurement of PWV for the three arterial segments indicated: aPWV = ascending aorta
PWV, daPWV = descending aorta PWV in the thoracoabdominal segment, if = iliofemoral PWV.
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is equivalent to the foot-to-foot technique commonly
utilized in tonometric studies [32]. This measurement
was performed for each heart beat and averaged over all
cardiac cycles.
For all arterial segments, PWV was calculated as:
PWV = L/Δt, where L is the path length of the pressure
wave between measurement sites, and Δt is the wave-
front propagation time averaged over multiple heart-
beats. For the thoracoabdominal aorta and iliofemoral
artery segments, path length was determined from the
anatomic axial images used for planning purposes. Spe-
cifically, the artery’s centroid was manually recorded
from the proximal descending aorta to the distal abdom-
inal aorta, corresponding to the measurement locations
of the velocity-encoded projections, and path length was
computed as the sum of the displacement of the vessel
centroid between slices. Similarly for the iliofemoral seg-
ment, the path length for the iliofemoral segment was
estimated the same way from the iliac bifurcation to the
popliteal artery. Finally, total PWV (tPWV) was com-
puted as the sum of path lengths along all three arterial
segments divided by the sum of propagation times.Ultrasound imaging
High-resolution B-mode ultrasound (US) images along
the arterial axis for measuring intimal-medial thickness
(IMT) of the common carotid artery, and flow-mediated
dilation (FMD) measurements of the brachial artery, wereobtained with a broadband high-frequency 9 L4 trans-
ducer using a Acuson Sequoia C512 scanner (Siemens
Medical Solution USA, Inc. Malvern, PA) by the same, ex-
perienced, technician. In general, the US was performed
on the day, or within two weeks of the CMR examination.
US scans were obtained with subjects at rest in a supine
position. The electrocardiogram was continuously moni-
tored and recorded on the ultrasound images. Carotid and
brachial artery examinations were performed in the same
session.Carotid ultrasound
The segments of the artery imaged included: (1) near
wall and far wall of the segment extending from 10 to
20 mm proximal to the tip of the flow divider into the
common carotid artery (CCA); (2) near wall and far wall
of the carotid bifurcation beginning at the tip of the flow
divider and extending 10 mm proximal to the flow div-
ider tip; and (3) near wall and far wall of the proximal
10 mm of the internal carotid artery (ICA). All images
were recorded as digital video clips with images trig-
gered on the R-wave.Flow mediated dilation (FMD)
Subject preparation and imaging protocol followed the
guidelines outlined by the task force for FMD measure-
ment of the brachial artery [33]. B-mode imaging and
spectral Doppler were performed 5–10 cm proximal to
the antecubital fossa in the longitudinal plane of the
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tify the lumen-wall interface. B-mode images were re-
corded as ten-frame video clips with images triggered on
R wave. Following the baseline imaging, the pressure
cuff, placed above the imaging transducer, was inflated
to 200 mm Hg for five minutes. The pressure cuff was re-
leased and the spectral Doppler was recorded for the first
10 seconds followed by 2 minutes of imaging. The R-wave
triggered B-mode images were recorded for diameter ana-
lysis at 1 and 2 minutes post pressure release.Ultrasound image analysis
Carotid images were analyzed for IMT and arterial diam-
eter using automated edge-detection software (Carotid
Analyzer for Research v5.0.5, MIA Vascular Research
Tools 5, Coralville, IA). Diameter was measured as the
distance between media-adventitia margin of the far and
near wall. Each measurement was performed in triplicate
and bilateral average CCA IMT values were obtained.
FMD was determined as the fractional change in bra-
chial artery diameter during hyperemia. Each analysis
was repeated three times and the average and standard
deviations was reported.Statistical analysis
Two-way ANOVA analysis was performed to determine
if effect of smoking and age could be separated from one
another. If there was no interaction between smoking
and age, one-way ANOVA was performed and followed
by post-hoc analysis of the parameters between the YNS
vs. YS, ONS vs. OS and YNS vs. ONS via unpaired
t-tests, with p < 0.05 being considered significant. Non-
parametric Wilcoxon tests were performed in situations
where parameters were not normally distributed. Fur-
ther, inter-parameter and inter-modality (CMR versus
US metrics) correlations were performed to evaluate as-
sociations between parameters derived with different
methods and between vascular territories. Associations
between conventional cardiovascular risk factor and im-
aging metrics were also examined using Spearman rank
correlation methods. All analyses were performed in
JMP (JMP®, Version 11, SAS Institute Inc., Cary, NC).Results
Two-way ANOVA indicated that there was no inter-
action between smoking and age (P = 0.40 -0.89) for all
parameters evaluated, which allowed combining smokers
in the young and older sub-groups and compare with all
nonsmokers. Additional comparisons of interest reported
in Table 2 are between old and young nonsmokers (age
effect) and smokers and nonsmokers within each of the
two age groups (smoking effect).Arterial blood flow at baseline and hyperemia
At baseline, the blood flow displays the typical tri-phasic
pattern during the cardiac cycle (systolic, retrograde and
late antegrade) (Figure 1b). However, with advancing age
the velocity wave is increasingly damped, as is evident
from the results in Table 2 showing that older subjects
had significantly greater pulse ratio (i.e. reduced diastolic
pulsatility, Va-Vr) than their younger peers (3.51 ± 0.08 ver-
sus 3.09 ± 0.08, P < 0.001). During hyperemia, blood flow
velocity is elevated, proceeding to a mono-phasic pattern,
eventually returning to baseline in 10–40 s (Figure 1c).
Smokers overall had lower hyperemic index than non-
smokers (1.01 ± 0.01 versus 1.25 ± 0.01, P < 0.01). None of
the other arterial flow measures differed significantly
among groups. Figure 5a,b show representative time-
courses of blood flow velocity in the femoral artery during
hyperemia for each of the four groups.
Venous oxygen saturation at baseline and hyperemia
Figure 5c,d display venous oxygen saturation curves dur-
ing hyperemia for representative subjects comparing
smokers and nonsmokers. Collectively, older subjects
had significantly lower SvO2 overshoot compared to
their younger peers (13.8 ± 0.99 vs. 18.5 ± 0.97%HbO2,
P < 0.001), as well as lower SvO2 upslope (2.43 ± 0.17 vs.
3.34 ± 0.17%HbO2/s, P < 0.001). Old non-smokers pre-
sented with lower overshoot (14.0 ± 1.35 vs. 19.9 ± 1.50%
HbO2, P < 0.001) and lower SvO2 upslope ratio (2.89 ±
0.24 vs. 3.74 ± 0.21%HbO2/s, P < 0.01) than young non-
smokers (Table 2). Smokers (young and old combined),
had lower SvO2 upslope compared to their non-smoking
peers (2.39 ± 0.18 vs. 3.33 ± 0.16%HbO2/s, P < 0.01).
Comparing only smokers to nonsmokers within an age
group, young smokers had lower SvO2 upslope (2.86 ±
0.25 vs. 3.74 ± 0.21%HbO2/s, P < 0.01), and longer wash-
out time (10.2 ± 0.51 vs. 9.00 ± 0.31 s, P < 0.05). The data
are commensurate with the notion of age- and smoking-
related impaired microvascular reactivity (Figure 6).
Pulse wave velocity
The pooled data in Table 2 comparing the two age groups
(old smokers and nonsmokers versus their younger peers)
indicate PWV for all segments as well as tPWV to be
highly significantly greater in the older subject group (P <
0.001), and primarily in the non-smoking groups (P <
0.05). However, there was no significant difference be-
tween smokers and nonsmokers even though for some
segments the differences approached significance, as for
example for the thoracoabdominal aorta (P = 0.08). Sub-
group analysis comparing smokers to nonsmokers within
each age group did not reveal significant differences.
Nevertheless, the data are suggestive of smokers to have
greater PWV than nonsmokers for all vascular segments
evaluated (Figure 6).
Table 2 Means and standard errors of CMR parameters derived from dynamic venous oximetry, arterial velocimetry and pulse-wave velocity measurements,
as well as inter-group differences
Metrics Y O NS S YNS YS ONS OS
Differences (%)
O-Y S-NS ONS-YNS YS-YNS OS-ONS
Dynamic oximetry
Overshoot (%HbO2) 18.5±0.97 13.8±0.99 17.0±0.97 15.2±1.05 19.9±1.50 17.1±1.28 14.0±1.35 13.4±1.31 –25.6*** –10.7 –29.4** –13.7 –4.4
Upslope (%HbO2/s) 3.34±0.17 2.43±0.17 3.33±0.16 2.39±0.18 3.74±0.21 2.86±0.25 2.89±0.24 1.94±0.22 –27.2*** –28.4*** –22.7** –23.6** –33.0**
Washout time (s) 9.53±0.38 10.6±0.39 9.37±0.37 10.8±0.40 9.00±0.31 10.2±0.51 9.77±0.44 11.4±0.84 11.1 15.3** 8.6 13.5* 16.3
Dynamic velocimetry
Pulse ratio 3.09±0.08 3.51±0.08 3.32±0.08 3.28±0.08 3.09±0.13 3.08±0.10 3.55±0.10 3.47±0.11 13.5*** −1.2 14.9** −0.5 −2.5
Hyperemic index 1.16±0.01 1.12±0.01 1.25±0.01 1.01±0.01 1.24±0.07 1.06±0.08 1.27±0.10 0.97±0.08 –3.9 –19.5** 2.1 –14.9 –23.4*
Forward flow time-TFF (s) 33.2±1.66 30.8±1.62 33.1±1.6 30.2±1.68 34.7±2.06 30.3±2.22 31.5±2.35 30.2±2.57 –7.2 –8.7 –9.3 –12.8 –3.9
Pulse-wave velocity (m/s)
Aortic arch 8.16±0.25 9.37±0.24 8.46±0.25 9.16±0.26 7.94±0.27 8.46±0.35 8.98±0.32 9.77±0.44 14.8*** 8.2 13.1* 6.5 8.8
Thoraco-abdominal 4.87±0.25 7.43±0.24 6.12±0.28 6.31±0.29 4.69±0.15 5.08±0.17 7.53±0.53 7.33±0.36 52.5*** 3.0 60.7*** 8.5 –2.6
Iliofemoral 6.78±0.21 8.08±0.21 7.31±0.22 7.57±0.23 6.72±0.24 6.79±0.23 7.91±0.26 8.26±0.43 19.2*** 3.6 17.7** 1.0 4.5
Total 5.93±0.13 7.54±0.13 6.65±0.15 6.88±0.16 5.80±0.10 6.06±0.13 7.48±0.20 7.60±0.26 27.1*** 3.5 29.0*** 4.4 1.6













Figure 6 Summary of most relevant inter-group comparisons: a-c) dynamic venous oximetry; d-f) PWV. Data suggest prolonged washout
time in smokers (a), reduced rate of re-saturation (upslope) in both smokers and older subjects (b), and similarly, lower overshoot (c). Age-related
increased arterial stiffness is evident for all three arterial segments (d-f). Significant p-values (P < 0.05) were highlighted in bold.
Figure 5 Post-cuff occlusion time course of blood flow velocity and SvO2 in femoral artery and vein, respectively. a, b) Femoral artery
velocity during hyperemia, comparing ONS to OS (a), and YNS to YS (b) in representative subjects. Note greater initial amplitude and shorter
forward flow (TFF) in nonsmokers; c, d) corresponding comparisons for femoral vein SvO2 time-course.
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Table 3 Means and standard errors for ultrasound derived measures (IMT and FMD), as well as inter-group differences
Metrics Y O NS S YNS YS ONS OS Differences (%)
O-Y S-NS ONS-YNS YS-YNS OS-ONS
Right CCA IMT (mm) 0.49 ± 0.01 0.66 ± 0.01 0.56 ± 0.02 0.60 ± 0.02 0.46 ± 0.01 0.52 ± 0.02 0.66 ± 0.02 0.68 ± 0.03 34.8*** 6.8 41.9*** 12.8 3.2
Left CCA IMT (mm 0.49 ± 0.02 0.70 ± 0.02 0.57 ± 0.02 0.63 ± 0.02 0.46 ± 0.01 0.53 ± 0.02 0.68 ± 0.02 0.72 ± 0.03 41.3*** 9.9* 49.3*** 16.6* 5.8
1-min FMD (%) 7.83 ± 0.69 7.04 ± 0.61 7.79 ± 0.63 6.93 ± 0.67 7.96 ± 0.96 7.66 ± 0.92 7.65 ± 0.96 6.38 ± 0.82 −10.1 −11.1 −3.9 −3.8 −16.6
2-min FMD (%) 6.61 ± 0.7 6.25 ± 0.64 6.85 ± 0.65 5.94 ± 0.68 6.99 ± 0.86 6.11 ± 0.92 6.71 ± 0.93 5.80 ± 1.03 −5.5 −13.3 −4.0 −12.6 −13.6
Y = young subjects, O = older subjects, NS = non-smoking, S = smoking.
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Ultrasound data are compiled in Table 3. Both right and
left common carotid artery (CCA) IMT was greater in the
older than in the young subject group (0.66 ± 0.01 vs.
0.49 ± 0.01 mm, P < 0.001, and 0.70 ± 0.02 vs. 0.49 ±
0.02 mm, P < 0.001, respectively). Importantly, left CCA
IMT was also greater in smokers compared to non-
smokers (0.63 ± 0.02 vs. 0.57 ± 0.02 mm, P < 0.05), espe-
cially in young smokers compared to their nonsmoking
peers (0.53 ± 0.02 vs. 0.46 ± 0.01 mm, P < 0.05). How-
ever, the difference in the right CCA IMT between
smokers and non-smokers was not significant. There
were no significant inter-group differences in FMD even
though there was a general trend of reduced FMD in
smokers and older subjects (P = 0.15 - 0.89).
Correlations of CMR parameters with other metrics
Inter-parameter correlations are listed in Table 4. While
correlations between parameters derived within the same
anatomic territory and representing similar properties
(e.g., parameters characterizing the kinetics of oxygen
re-saturation during hyperemia, or arterial flow velocity
at baseline and hyperemia) are unsurprising, of interest
are associations between measures representative of dif-
ferent vascular territories or between oximetric and
arterial flow measures. For example descending aortic
PWV was negatively correlated with SvO2 upslope
(r = −0.31, P < 0.001). The relationship between increased
stiffness of central artery and reduced vascular reactivity
further supports the hypothesis that increased PWV
leads to increased transmission of deleterious pulse pres-
sure to the peripheral bed [34].
Significant associations were also seen between im-
aging measures and cardiovascular risk factors. All
PWVs correlated with SBP (r = 0.27-0.42, P < 0.001). In
non-smokers, the BMI and C-reactive protein levelsTable 4 Spearman correlation coefficients for inter-parameter
(N = 169)
Correlation Oximetry
OS Upslope Washout PR
Washout -
Upslope 0.45 -
OS −0.14 −0.42 -
PR −0.34 −0.17 0.11 -
HI 0.17 0.23 −0.10 0.04
TFF −0.02 −0.01 −0.04 0.19
aPWV −0.22 −0.12 0.05 0.22
daPWV −0.19 −0.31 0.24 0.22
ifPWV −0.12 −0.14 0.09 0.18
aPWV = aortic arch PWV, daPWV = thoracoabdominal aortic PWV, and ifPWV = iliofem
Significant correlations (P < 0.05, corresponding to |r| > 0.15) are bolded.correlated with microvascular CMR parameters, includ-
ing forward flow time TFF, HI, and PR as well as SvO2
overshoot, upslope and washout time (r = 0.16 – 0.97,
P < 0.05). Further, total PWV, calculated as a total path
length divided by the total transit time over the three ar-
terial segments, correlated with cumulative cigarette
smoke exposure expressed in terms of pack years in
smokers (r = 0.52, P < 0.001, Figure 7). Lastly, carotid
IMT in young smokers correlated with PWV at all three
locations (r = 0.21 – 0.45, all P < 0.01), similarly between
IMT and microvascular CMR parameters including PR
and HI, SvO2 overshoot, upslope and washout time (r =
0.16-0.53, P < 0.05). No other significant correlations
were found between CMR metrics and either laboratory
findings or ultrasound FMD results.Discussion and conclusions
The focus of the present study was to evaluate the ef-
fects of aging and smoking on surrogate markers of
endothelial function in the form of new quantitative
CMR measures obtained in the peripheral and central
vasculature. The approach chosen is unique in that it al-
lows quantification of parameters of microvascular as
well as macrovascular functional and mechanical proper-
ties (response to hyperemia, arterial wave-form analysis
and arterial compliance) as part of a single, integrated
examination using novel CMR methods and comparing
results to conventional ultrasound measures. The study
population was chosen so as to allow detection of early,
preclinical manifestations of noninvasively measurable
parameters in subjects without overt cardiovascular dis-
ease. One important and unexpected outcome of the
study is the finding that for all functional parameters
evaluated the effects of smoking and age were independ-
ent of one another.correlations of CMR measures involving the entire cohort
PWV




0.00 −0.07 0.23 -
0.10 0.09 0.35 0.29 -
oral arterial PWV.
Figure 7 Significant correlation between smoking severity
(cigarette pack-years) and total PWV (tPWV) along three arterial
segments in smokers was found (r = 0.52, P < 0.001). Dotted line
denotes 95% confidence interval of the linear fitting of cigarette
pack-years to tPWV.
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flow-mediated dilation of the brachial artery via B-mode
ultrasound [33], which has provided insights into abnormal
endothelial function in subjects with cardiovascular risk fac-
tors, and in relationship to age and smoking [35-37]. Here,
the main target toward assessment of microvascular re-
activity and endothelial function was the femoro-popliteal
circulation, given that atherosclerotic disease is far more
prevalent in the lower than in upper extremities. New
CMR methods recently introduced by some of the present
authors allow simultaneous evaluation of both arterial as
well as venous response to cuff-induced ischemia [21]. The
two approaches are complementary, mapping the temporal
evolution of arterial velocity via high temporal-resolution,
projection-based, phase-contrast imaging [28], and SvO2
via field mapping, which is measured dynamically during
hyperemia in the femoral vein [21] (see Figure 2).
For the latter method, washout time, the period be-
tween restoration of flow after cuff-occlusion, and the
minimum of the SvO2-time curve, was significantly pro-
longed in the young smoking group. Similarly, the rate
of recovery, termed upslope, expressed in terms of the
rate of change, Δ(SvO2)/Δt, was lower in the older rela-
tive to that in the younger subject group. Further, over-
shoot, the transient increase above baseline, of the
SvO2-time curve, was reduced in the older compared to
the younger study subjects. Importantly, in both young
and older study groups, smokers exhibited similar im-
pairments of endothelial function in terms of the three
oximetric parameters (see Figure 6a-c). Complementing
the hyperemic oximetry data was the hyperemic index (HI)
following cuff deflation, which in the older subject group
was significantly lower in smokers relative to nonsmokers.Our findings are commensurate with the notion that
both age and smoking promote impaired, nitric oxide
dependent, microvascular reactivity [38]. There exist no
data in the literature other than our own in patients with
peripheral arterial disease, in which the dynamic venous
oximetric parameters proved to be strong differentiators
of subjects with peripheral arterial disease, from controls
[21,22]. Brachial artery FMD, measured in the present
study for comparison, has long been regarded as a bio-
marker for NO-dependent endothelial function (see, for
example, ref. [39] and thus provides a means for com-
parison. In a small quantitative CMR study comparing
young smokers to matched nonsmokers, Wiesmann
et al. had found reduced brachial artery FMD measured
from the change in cross-sectional area of the brachial
artery [20]. These findings parallel those by Celermajer
et al. [35], who found in a cohort of 200 subjects divided
into controls, current and former smokers, all normo-
tensive without a history of premature vascular disease,
that brachial artery FMD, measured by B-mode US, to
be reduced in smokers. Our reference, brachial-artery
FMD data obtained via B-mode ultrasound, suggest
lower FMD in smokers within an age group, as well as
in older compared to younger nonsmokers, albeit with-
out reaching significance, which might be due to the
relatively small group sizes. On the other hand, the base-
line femoral artery velocity waveform, characterized in
terms of the pulse ratio (a measure of the extent of
damping of the pulsatility during diastole), was signi-
ficantly higher in the older relative to the younger
nonsmoking subject group, indicative of the vessel’s im-
paired viscoelastic properties.
The second element of our CMR protocol centered on
the evaluation of pulse-wave velocity along two succes-
sive aortic segments (aortic arch, thoracoabdominal
aorta), involving image-based measurement of the path
length. We also assessed iliofemoral PWV, which has
not previously been reported. The data are of interest
given that conventionally-derived, carotid to femoral
PWV, has been shown to be positively correlated with
age [40] while the effect of smoking yielded less conclu-
sive results (see, for instance, Doonan et al. [19] for a
meta analysis). Our data were strongly associated with
age, indicating older non-smokers to have elevated PWV
in all three segments relative to their younger peers
(Figure 6 and Table 2). However, the thoracoabdominal
segment demonstrated the largest age effect where
group means of older nonsmokers were 60% greater
than those in the younger nonsmoking subject group, in
agreement with recently reported CMR-based regional
measurements [41]. Further, our results indicate positive
correlations with SBP and PWV for all three segments
as well as with total PWV. The data in Figure 6d-f sug-
gest that within an age group smokers had increased
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not reach significance. However, when plotted against
smoking severity, total PWV was found to increase with
the number of pack-years (Figure 7).
Recently, Koivistoinen et al. [42] reported an inverse
relationship between carotid distensibility and IMT, sug-
gesting that elevated PWV may be governed by similar
factors that determine preclinical increases in arterial
wall thickness. Even though our pulse-wave velocities
were not measured at the same anatomic location, we
found the values in the three segments to be positively
correlated with carotid IMT, indicative of a systemic ef-
fect. Our IMT data were strongly associated with both
age and smoking, showing mean values on both sides to
be significantly greater than those in the younger subject
group. Finally, IMT in young smokers was elevated rela-
tive to that of their nonsmoking peers, in line with early
data, which provided evidence for smoking to contribute
independently to increased IMT [43].
Both, the methods used, and study design, have limita-
tions. The analysis of the raw data, in particular the time-
course measures, is involved and operator-intensive, and
will need to be streamlined for future large-scale studies.
However, we enrolled only subjects with BMI < 30, which
excludes a substantial fraction of the general population.
As far as the study itself is concerned, there may be con-
founds masking the effect of smoking, such as lifestyle fac-
tors (e.g. exercise), and the lifetime exposure to smoking,
which need to be captured in future follow-up studies.
The demographics in Table 1 may suggest race as a
possible confound. Since, as previously stated, two-way
ANOVA did not show a statistically significant interaction
between age and smoking, regression with and without
race as a variable was performed to determine if the
covariate changed the effects of age and smoking. The
results of the analysis showed no statistically significant
effect in any of the MR parameters. Thus, the slight
imbalance in racial distribution should not affect the
work’s overall conclusions.
Unique to the approach presented in the present work
is CMR’s ability to quantify a spectrum of biomarkers of
vascular health, both at the micro- and macrovascular
level, as part of a single examination. The work is the first
to examine the effects of cigarette smoking and aging on
new measures of vascular reactivity and endothelial dys-
function in subjects without symptomatic cardiovascular
disease. Unlike ultrasound, where inter-operator errors
(for example from transducer placement) adversely affect
repeatability, CMR is more stable as the choice of the
measurement location is entirely image-guided.
In summary, while these early data are promising, cor-
roborative studies in larger cohorts will be needed, along
with rigorous comparison with more established methods.
Of particular interest will be to ascertain whether themethods are able to quantify longitudinal changes such as
those resulting as a consequence of aging or smoking
cessation.
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